Profile data is unavailable for this security.
About the company
PT Merck Tbk is an Indonesia-based vibrant science and technology company. The Company delivers personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. The Company operates through three segments: Biopharma (ethical products), Consumer Health (over-the-counter products) and Others.
- Revenue in IDR (TTM)934.43bn
- Net income in IDR134.07bn
- Incorporated1970
- Employees377.00
- LocationMerck Tbk PTJl. TB. Simatupang No. 8, Pasar ReboJAKARTA TIMUR 13760IndonesiaIDN
- Phone+62 28565600
- Fax+62 28565601
- Websitehttps://www.merckgroup.com/id-id
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indofarma Tbk PT | 269.35bn | -702.59bn | 390.51bn | 900.00 | -- | -- | -- | 1.45 | -226.69 | -226.69 | 86.91 | -292.35 | 0.2263 | 2.69 | 1.99 | 248,022,500.00 | -59.03 | -15.78 | -- | -37.17 | -62.99 | 12.54 | -260.85 | -16.15 | 0.142 | -9.03 | -- | -- | -46.59 | -19.95 | -57.55 | -- | -36.74 | -- |
Ikapharmindo Putramas Tbk PT | 424.36bn | 8.81bn | 498.66bn | 1.03k | 56.58 | 2.03 | -- | 1.18 | 5.23 | 5.23 | 251.90 | 145.57 | -- | -- | -- | 417,266,400.00 | -- | -- | -- | -- | 43.87 | -- | 2.08 | -- | 1.28 | 2.24 | 0.3803 | -- | 10.63 | -- | -7.48 | -- | -- | -- |
Merck Tbk PT | 934.43bn | 134.07bn | 1.69tn | 377.00 | 12.60 | 2.41 | 9.92 | 1.81 | 299.27 | 299.27 | 2,085.79 | 1,561.87 | 1.00 | 1.46 | 6.10 | 2,395,979,000.00 | 14.39 | 12.78 | 18.11 | 18.12 | 37.34 | 40.53 | 14.35 | 14.06 | 1.36 | -- | 0.026 | 79.25 | -14.51 | 9.46 | -0.8884 | 36.67 | -3.13 | -34.05 |
Pyridam Farma Tbk PT | 795.77bn | -142.37bn | 1.73tn | 1.33k | -- | 1.28 | -- | 2.17 | -41.98 | -41.98 | 170.10 | 120.12 | 0.2073 | 1.37 | 2.16 | 667,036,500.00 | -3.99 | 6.31 | -6.16 | 8.07 | 38.35 | 42.56 | -19.23 | 8.83 | 0.5474 | -0.5882 | 0.7473 | -- | -1.87 | 22.89 | -130.96 | -- | 2.93 | -- |
Darya-Varia Laboratoria Tbk PT | 2.00tn | 169.38bn | 1.91tn | 1.27k | 11.29 | 1.32 | 8.15 | 0.9569 | 150.98 | 150.98 | 1,779.93 | 1,294.73 | 0.9229 | 2.11 | 2.62 | 1,572,631,000.00 | 7.83 | 8.45 | 10.45 | 11.41 | 51.74 | 52.21 | 8.49 | 8.83 | 1.93 | -- | 0.0009 | 75.64 | -1.36 | 2.16 | -2.03 | -6.12 | 16.57 | 0.1862 |
Enseval Putera Megatrading Tbk PT | 30.04tn | 708.74bn | 6.69tn | 5.17k | 9.45 | 0.9337 | 7.55 | 0.2227 | 261.36 | 261.36 | 11,071.46 | 2,645.41 | 2.72 | 6.98 | 6.81 | 5,873,683,000.00 | 6.41 | 7.63 | 9.92 | 10.80 | 10.03 | 10.71 | 2.36 | 2.86 | 1.42 | 65.22 | 0.0654 | 64.35 | 1.71 | 6.71 | -18.76 | 1.06 | 8.20 | 13.02 |
Soho Global Health Tbk PT | 9.12tn | 443.39bn | 8.44tn | 2.35k | 19.04 | 3.22 | 16.51 | 0.9255 | 34.94 | 34.94 | 718.57 | 206.80 | 1.78 | 5.47 | 5.14 | 3,843,169,000.00 | 8.66 | 7.97 | 16.02 | 14.37 | 15.82 | 19.39 | 4.86 | 4.65 | 1.28 | -- | 0.0054 | -- | 12.45 | 12.43 | 4.10 | 49.70 | 21.21 | -- |
Data as of Sep 19 2024. Currency figures normalised to Merck Tbk PT's reporting currency: Indonesian Rupiah IDR
Holder | Shares | % Held |
---|---|---|
Samarang LLPas of 30 Jun 2022 | 2.92m | 0.65% |
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.